Immunogenicity and Reactogenicity of Avaxim (160 AU) as Compared with Havrix (1440 EL.U) as a Booster Following Primary Immunization with Havrix (1440 EL.U) against Hepatitis A

Abstract

Either Avaxim or Havrix may be given as a booster dose of hepatitis A vaccine when Havrix has been administered as the primary dose.